Accueil > Actualité
Actualite financiere : Actualite bourse

Eli Lilly: extends tender offer for Point Biopharma

(CercleFinance.com) - Eli Lilly has announced that it has extended the expiry date of its tender offer to acquire all of the issued and outstanding shares of common stock of Point Biopharma Global for a purchase price of $12.
50 per share in cash.

The tender offer, which was set to expire at 5 pm on 16 November 2023, has been extended to 5 pm on 1 December 2023, unless the tender offer is extended or terminated earlier, in order for the parties to satisfy the minimum tender condition.

All necessary regulatory approvals to complete the transaction have been obtained.


Copyright (c) 2023 CercleFinance.com. All rights reserved.
 

societes

marches

tendances

 
Qui sommes-nous ? | Nous contacter | FAQ | Mentions légales | RSS | © Copyright 2007 Cercle Finance. Tous droits réservés.